Renal Metabolome in Obese Mice Treated with Empagliflozin Suggests a Reduction in Cellular Respiration
Sodium glucose cotransporter, type 2 inhibitors, such as Empagliflozin, are protective of the kidneys by unclear mechanisms. Our aim was to determine how Empagliflozin affected kidney cortical metabolome and lipidome in mice. Adult male TALLYHO mice (prone to obesity) were treated with a high-milk-f...
Main Authors: | Surabhi Bangarbale, Blythe D. Shepard, Shivani Bansal, Meth M. Jayatilake, Ryan Kurtz, Moshe Levi, Carolyn M. Ecelbarger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/12/9/1176 |
Similar Items
-
Insulin-induced mTOR signaling and gluconeogenesis in renal proximal tubules: A mini-review of current evidence and therapeutic potential
by: Motonobu Nakamura, et al.
Published: (2022-10-01) -
Comparative study of sodium-dependent glucose co-transporters in kidneys of Ostrich chickens
by: Piret Hussar, et al.
Published: (2022-07-01) -
Suggestions for attenuation of renal ischemia reperfusion injury based on mechanisms involved in epithelial cells damages
by: Tavafi Majid
Published: (2015-01-01) -
Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway
by: Xiaochen Yu, et al.
Published: (2022-03-01) -
Ang II acutely stimulates Na,K‐pump in cells from proximal tubules by increasing its phosphorylation at S938 via a PI3K/AKT pathway
by: Fadia S. Hanna, et al.
Published: (2022-11-01)